Investor Relations

Press Releases

08/05/20
Conformis Reports Second Quarter 2020 Financial Results and Announces Planned Portfolio Expansion Targeted at Ambulatory Surgical Centers
BILLERICA, Mass. , Aug. 05, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the second quarter ended June 30, 2020 . Second Quarter 2020 Summary Total revenue of $19.5 million , a decrease of 1% year-over-year on a reported and constant currency basis.
07/23/20
Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
BILLERICA, Mass. , July 23, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that management will present at the Canaccord Genuity 40th Annual Growth Conference. The event is being held virtually and will take place between August 11 and 13, 2020 .
07/06/20
Conformis Reports Preliminary Second Quarter Revenue Results, Amendment to Credit Agreement
Earnings Call to be Hosted on August 5, 2020 BILLERICA, Mass. , July 06, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to
06/22/20
Conformis Announces 510(k) Clearance for iTotal® Identity PS
iTotal® Identity PS joins iTotal® Identity CR as the latest personalized knee technology from Conformis BILLERICA, Mass. , June 22, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation
05/28/20
Conformis Announces Settlement of Patent Dispute
Conformis and Zimmer Biomet settled disputes related to Patient-Specific Instrument Patents for Use with Off-the-Shelf Knee, Hip, and Shoulder Implants BILLERICA, Mass. , May 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license
05/21/20
Prestigious Klee Family Foundation Prize 2020 Awarded for Outstanding Scientific Work Identifying Patient-Specific Approach as Better Way to Optimize Knee Implant Design
Dr. Malte Asseln awarded annual prize by German Society for Biomedical Engineering at the VDE Association and the Klee Family Foundation for his scientific computer-and-image-based workflow to optimize knee implant design BILLERICA, Mass. , May 21, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc.
05/11/20
Conformis Reports First Quarter 2020 Financial Results
BILLERICA, Mass. , May 11, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific joint replacement implants designed to fit each patient's unique
05/05/20
Conformis to Host First Quarter 2020 Financial Results Webcast on May 11, 2020
BILLERICA, Mass. , May 05, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast and conference call on Monday, May 11, 2020 , at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2020 .  The webcast will be
04/23/20
Conformis Announces Return to Work of Furloughed Employees
Government Relief, Anticipated Relaxing of Restrictions on Elective Surgeries Leads to Return to Work BILLERICA, Mass. , April 23, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that, due in large part to a loan made available to the Company under the Paycheck Protection
04/20/20
Conformis Receives $4.7 Million under the Paycheck Protection Program
BILLERICA, Mass. , April 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced that on April 17, 2020 the Company entered into a $4,719,800 promissory note with East West Bank (NASDAQ:EWBC) under the Paycheck Protection Program (“PPP”) offered by the U.S.
04/09/20
Conformis to Hold Virtual Annual Meeting of Stockholders on April 27, 2020
BILLERICA, Mass. , April 09, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ: CFMS) today announced that, due to the public health impact of the novel coronavirus outbreak and governmental restrictions limiting the number of people who may gather together, and to support the health and well-being
03/23/20
Conformis Announces Actions to Mitigate COVID-19 Impact
Withdraws Previous 2020 Growth Outlook Implementing furlough of approximately 1/3 of its direct workforce and substantially all of its temporary workforce Furloughed employees will be immediately eligible for unemployment benefits and will maintain their existing healthcare coverage through
03/02/20
Conformis Reports Fourth Quarter and Year End 2019 Financial Results
BILLERICA, Mass. , March 02, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today financial results for the fourth quarter and year ended December 31, 2019 . Q4 Summary Total revenue of $19.9 million , down 10% year-over-year on a reported basis and 9% on a constant currency
02/21/20
Conformis, Inc. to Present at the Cowen 40th Annual Health Care Conference
BILLERICA, Mass. , Feb. 21, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped,
02/20/20
Conformis to Host Fourth Quarter and Fiscal Year 2019 Financial Results Webcast on March 2, 2020
BILLERICA, Mass. , Feb. 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast and conference call on Monday, March 2, 2020 , at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31 , 2019. 
02/19/20
Conformis iTotal® CR Knee Replacement System Awarded “5A” Rating from the Orthopaedic Data Evaluation Panel in the United Kingdom
Rating Highlights Positive Five-Year Survivorship Following Total Knee Arthroplasty BILLERICA, Mass. , Feb. 19, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ: CFMS ), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and
02/05/20
Conformis Appoints Bob Howe as Chief Financial Officer
Also Announces Gary Maingot as SVP, Operations; New Executive Leadership Team Members Contribute Deep Functional Expertise and Technical Knowledge; Inducement Grants Reported BILLERICA, Mass. , Feb. 05, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS), a medical technology company that uses
01/30/20
Conformis Achieves 100,000 Implant Milestone for Patient-Specific Knee Replacement Technology
Conformis’ Patient-Specific Knee Implant Technology Is Complemented by New 3D-designed Hip System Launched in November 2019 BILLERICA, Mass. , Jan. 30, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology
01/14/20
Conformis Reports Preliminary Fourth Quarter and Year-End 2019 Revenue Results
BILLERICA, Mass. and SAN FRANCISCO , Jan. 14, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique